Neurocrine Biosciences (NBIX) Tops Q1 EPS by 77c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $158.29 --0%
EPS Growth %: -5.5%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -5.5%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of $1.94, $0.77 better than the analyst estimate of $1.17. Revenue for the quarter came in at $811 million versus the consensus estimate of $766.85 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
- H.C. Wainwright Starts Conexeu Sciences (CNXU) at Buy
- Micron Technology (MU) call put ratio 1 calls to 1.1 puts into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
